![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model
Charlotte Primard, Élodie Monchâtre-Leroy, Judith del Campo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Charlotte Primard, Élodie Monchâtre-Leroy, Judith del Campo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Showing 19 citing articles:
In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms
S. Cankat, M. U. Demael, Leo Swadling
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 103-118
Open Access | Times Cited: 22
S. Cankat, M. U. Demael, Leo Swadling
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 103-118
Open Access | Times Cited: 22
Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
Mie Suzuki-Okutani, Shinya Okamura, Tanggis, et al.
(2025)
Open Access
Mie Suzuki-Okutani, Shinya Okamura, Tanggis, et al.
(2025)
Open Access
Protective potential of structural proteins of the SARS-CoV-2 virus in protecting against COVID-19
Inna V. Dolzhikova, Daria M. Grousova, Ilya D. Zorkov, et al.
Journal of microbiology epidemiology immunobiology (2025) Vol. 101, Iss. 6, pp. 769-778
Open Access
Inna V. Dolzhikova, Daria M. Grousova, Ilya D. Zorkov, et al.
Journal of microbiology epidemiology immunobiology (2025) Vol. 101, Iss. 6, pp. 769-778
Open Access
Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody response
Charles O. Noble, Ellie McDonald, Suellen Nicholson, et al.
Journal of Infection (2025), pp. 106436-106436
Open Access
Charles O. Noble, Ellie McDonald, Suellen Nicholson, et al.
Journal of Infection (2025), pp. 106436-106436
Open Access
Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
Mie Suzuki-Okutani, Shinya Okamura, Tang Gis, et al.
eLife (2025) Vol. 13
Open Access
Mie Suzuki-Okutani, Shinya Okamura, Tang Gis, et al.
eLife (2025) Vol. 13
Open Access
Combined immunization with SARS-CoV-2 spike and SARS-CoV nucleocapsid protects K18-hACE2 mice but increases lung pathology
Jae‐Kwan Kim, A. V. Kachko, Prabhuanand Selvaraj, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Jae‐Kwan Kim, A. V. Kachko, Prabhuanand Selvaraj, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein
Noe Juvenal Mendoza-Ramírez, Julio García‐Cordero, Gaurav Shrivastava, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-18
Open Access | Times Cited: 4
Noe Juvenal Mendoza-Ramírez, Julio García‐Cordero, Gaurav Shrivastava, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-18
Open Access | Times Cited: 4
N-protein vaccine is effective against COVID-19: phase 3, randomized, double-blind, placebo-controlled clinical trial
Sevastyan O. Rabdano, Ellina Ruzanova, Anastasiya Evgenievna Vertyachikh, et al.
Journal of Infection (2024), pp. 106288-106288
Open Access | Times Cited: 4
Sevastyan O. Rabdano, Ellina Ruzanova, Anastasiya Evgenievna Vertyachikh, et al.
Journal of Infection (2024), pp. 106288-106288
Open Access | Times Cited: 4
A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model
Swayam Prakash, Nisha R. Dhanushkodi, Mahmoud Singer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Swayam Prakash, Nisha R. Dhanushkodi, Mahmoud Singer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Overview of Nucleocapsid-Targeting Vaccines against COVID-19
Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko
Vaccines (2023) Vol. 11, Iss. 12, pp. 1810-1810
Open Access | Times Cited: 9
Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko
Vaccines (2023) Vol. 11, Iss. 12, pp. 1810-1810
Open Access | Times Cited: 9
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
Sabrina Clever, Leonard Limpinsel, Christian Meyer zu Natrup, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 417-417
Open Access | Times Cited: 2
Sabrina Clever, Leonard Limpinsel, Christian Meyer zu Natrup, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 417-417
Open Access | Times Cited: 2
Unraveling the role of the nucleocapsid protein in SARS-CoV-2 pathogenesis: From viral life cycle to vaccine development
Yousra A. El‐Maradny, Moustafa A. Badawy, Kareem I. Mohamed, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135201-135201
Closed Access | Times Cited: 2
Yousra A. El‐Maradny, Moustafa A. Badawy, Kareem I. Mohamed, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135201-135201
Closed Access | Times Cited: 2
Co-administration of recombinant BCG and SARS-CoV-2 proteins leads to robust antiviral immunity
Mario A. Ramírez, Ricardo A. Loaiza, Yohana Martínez-Balboa, et al.
Vaccine (2024) Vol. 42, Iss. 23, pp. 126203-126203
Closed Access | Times Cited: 1
Mario A. Ramírez, Ricardo A. Loaiza, Yohana Martínez-Balboa, et al.
Vaccine (2024) Vol. 42, Iss. 23, pp. 126203-126203
Closed Access | Times Cited: 1
Cell surface RNA virus nucleocapsid proteins: a viral strategy for immunosuppression?
Alberto Domingo López-Muñoz, Jonathan W. Yewdell
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Alberto Domingo López-Muñoz, Jonathan W. Yewdell
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Coronavirus Nucleocapsid-based Vaccine Provides Partial Protection against Hetero-species Coronavirus in Murine Models
Pureum Lee, Jihee Kim, Hanseul Oh, et al.
Antiviral Research (2024) Vol. 231, pp. 105991-105991
Closed Access
Pureum Lee, Jihee Kim, Hanseul Oh, et al.
Antiviral Research (2024) Vol. 231, pp. 105991-105991
Closed Access
Enhanced Detection and Molecular Modeling of Adaptive Mutations in SARS-CoV-2 Coding and Non-Coding Regions Using the c/µ Test
Nicholas J. Paradis, Chun Wu
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access
Nicholas J. Paradis, Chun Wu
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access
Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice
Maria V. Sergeeva, Kirill Vasilev, Ekaterina A. Romanovskaya-Romanko, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 15-15
Open Access
Maria V. Sergeeva, Kirill Vasilev, Ekaterina A. Romanovskaya-Romanko, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 15-15
Open Access
Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines
Aziz Alami Chentoufi, Jeffrey B. Ulmer, Lbachir BenMohamed
Vaccines (2024) Vol. 13, Iss. 1, pp. 30-30
Open Access
Aziz Alami Chentoufi, Jeffrey B. Ulmer, Lbachir BenMohamed
Vaccines (2024) Vol. 13, Iss. 1, pp. 30-30
Open Access
Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
Mie Suzuki-Okutani, Shinya Okamura, Tanggis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mie Suzuki-Okutani, Shinya Okamura, Tanggis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
Mie Suzuki-Okutani, Shinya Okamura, Tang Gis, et al.
(2024)
Open Access
Mie Suzuki-Okutani, Shinya Okamura, Tang Gis, et al.
(2024)
Open Access
Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
Mie Suzuki-Okutani, Shinya Okamura, Tang Gis, et al.
eLife (2024) Vol. 13
Open Access
Mie Suzuki-Okutani, Shinya Okamura, Tang Gis, et al.
eLife (2024) Vol. 13
Open Access
A longitudinal study on SARS-CoV-2 seroconversion, reinfection and neutralisation spanning several variant waves and vaccination campaigns, Heinsberg, Germany, April 2020 to November 2022
Bianca Schulte, Enrico Richter, Antonia Büning, et al.
Eurosurveillance (2024) Vol. 29, Iss. 26
Open Access
Bianca Schulte, Enrico Richter, Antonia Büning, et al.
Eurosurveillance (2024) Vol. 29, Iss. 26
Open Access